Release Date: 08/11/11 17:06 Summary: Daily share buy-back notice - Appendix 3E Price Sensitive: No Download Document 87.65KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%